Heterogeneous responses of IM19 anti-CD19 CAR T-cell therapy in refractory systemic lupus erythematosus: an open-label pilot study and a mini-review

Journal:
Annals of the Rheumatic Diseases
Published:
DOI:
10.1016/j.ard.2025.12.014
Affiliations:
10
Authors:
23
Go to article
Institutions Authors Share
Peking University Third Hospital (PUTH), PKUHSC, China
17.000000
17.000000
 0.74
Imunopharm, China
5.000000
 0.22
Qilu Hospital of Shandong University, China
1.000000
 0.04
Interested in Oncology and Carcinogenesis?